Efficacy of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Scheduled to Undergo Invasive Procedures

OBJECTIVE: Lusutrombopag is a thrombopoietin receptor agonist that improves thrombocytopenia in patients with chronic liver disease scheduled to undergo invasive procedures. However, information on the efficacy of repeated lusutrombopag treatment and factors associated with the treatment is scarce....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Intern Med
Autori principali: Nishida, Yuno, Kawaoka, Tomokazu, Imamura, Michio, Namba, Maiko, Fujii, Yasutoshi, Uchikawa, Shinsuke, Ohya, Kazuki, Daijo, Kana, Teraoka, Yuji, Morio, Kei, Fujino, Hatsue, Nakahara, Takashi, Yamauchi, Masami, Hiramatsu, Akira, Tsuge, Masataka, Aikata, Hiroshi, Takahashi, Shoichi, Hayes, C. Nelson, Fukuhara, Takayuki, Tsuji, Keiji, Arataki, Keiko, Nagaoki, Yuko, Aisaka, Yasuyuki, Kamada, Koji, Kodama, Hideaki, Chayama, Kazuaki
Natura: Artigo
Lingua:Inglês
Pubblicazione: The Japanese Society of Internal Medicine 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8024946/
https://ncbi.nlm.nih.gov/pubmed/33087674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5930-20
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi